Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Alopecia universalis can be an early sign of HIV.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

Azathioprine may be an effective treatment for severe hair loss.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Most patients with small patches of hair loss usually regrow hair.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Eyelash regrowth occurred after eyelid surgery in a man with severe hair loss.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

PUVASOL might effectively treat complete scalp baldness.